TR200400375T3 - Taksanlarin sabit araliklarla dozlanmasi - Google Patents

Taksanlarin sabit araliklarla dozlanmasi

Info

Publication number
TR200400375T3
TR200400375T3 TR200400375T TR200400375T TR200400375T3 TR 200400375 T3 TR200400375 T3 TR 200400375T3 TR 200400375 T TR200400375 T TR 200400375T TR 200400375 T TR200400375 T TR 200400375T TR 200400375 T3 TR200400375 T3 TR 200400375T3
Authority
TR
Turkey
Prior art keywords
taxanes
dosage
fixed intervals
intervals
fixed
Prior art date
Application number
TR200400375T
Other languages
English (en)
Inventor
Joseph Fargnoli
William C Rose
Pamela Trail
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of TR200400375T3 publication Critical patent/TR200400375T3/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Carpets (AREA)
  • Epoxy Compounds (AREA)
TR200400375T 2001-02-28 2002-02-26 Taksanlarin sabit araliklarla dozlanmasi TR200400375T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28

Publications (1)

Publication Number Publication Date
TR200400375T3 true TR200400375T3 (tr) 2004-04-21

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200400375T TR200400375T3 (tr) 2001-02-28 2002-02-26 Taksanlarin sabit araliklarla dozlanmasi

Country Status (31)

Country Link
EP (1) EP1372636B1 (tr)
JP (1) JP2004538253A (tr)
KR (1) KR20030086276A (tr)
CN (1) CN1533273A (tr)
AR (1) AR033609A1 (tr)
AT (1) ATE331511T1 (tr)
BG (1) BG108167A (tr)
BR (1) BR0207519A (tr)
CA (1) CA2439299A1 (tr)
CY (1) CY1105468T1 (tr)
CZ (1) CZ20032232A3 (tr)
DE (2) DE02723255T1 (tr)
DK (1) DK1372636T3 (tr)
EE (1) EE200300413A (tr)
ES (1) ES2211374T3 (tr)
HR (1) HRP20030775A2 (tr)
HU (1) HUP0402115A2 (tr)
IL (1) IL157356A0 (tr)
IS (1) IS6924A (tr)
MX (1) MXPA03007655A (tr)
NO (1) NO20033809L (tr)
PE (1) PE20020955A1 (tr)
PL (1) PL373376A1 (tr)
PT (1) PT1372636E (tr)
RU (1) RU2003129233A (tr)
SK (1) SK10332003A3 (tr)
TR (1) TR200400375T3 (tr)
UY (1) UY27185A1 (tr)
WO (1) WO2002067928A2 (tr)
YU (1) YU66603A (tr)
ZA (1) ZA200306450B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US20080063699A1 (en) * 2003-10-15 2008-03-13 Michael Teifel Method of Administering Cationic Liposomes Comprising an Active Drug
AU2006243337B2 (en) 2005-05-04 2011-09-29 Syncore Biotechnology Co., Ltd Method of administering a cationic liposomal preparation comprising paclitaxel
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0003546A3 (en) * 1997-05-27 2002-12-28 Baker Norton Pharma Compositions for administering taxanes orally to human patients
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
EE200300413A (et) 2003-12-15
DK1372636T3 (da) 2006-11-06
MXPA03007655A (es) 2003-12-04
WO2002067928A2 (en) 2002-09-06
HUP0402115A2 (hu) 2005-02-28
ATE331511T1 (de) 2006-07-15
PT1372636E (pt) 2006-09-29
YU66603A (sh) 2006-08-17
BG108167A (en) 2004-09-30
NO20033809D0 (no) 2003-08-27
RU2003129233A (ru) 2005-02-10
HRP20030775A2 (en) 2005-02-28
SK10332003A3 (sk) 2005-03-04
CY1105468T1 (el) 2010-04-28
PE20020955A1 (es) 2002-10-30
WO2002067928A3 (en) 2003-10-09
CZ20032232A3 (en) 2004-06-16
DE02723255T1 (de) 2004-07-15
EP1372636A2 (en) 2004-01-02
ES2211374T1 (es) 2004-07-16
ES2211374T3 (es) 2007-03-01
IL157356A0 (en) 2004-02-19
DE60212813D1 (de) 2006-08-10
JP2004538253A (ja) 2004-12-24
ZA200306450B (en) 2004-11-19
IS6924A (is) 2003-08-22
NO20033809L (no) 2003-10-23
PL373376A1 (en) 2005-08-22
AR033609A1 (es) 2003-12-26
EP1372636B1 (en) 2006-06-28
CN1533273A (zh) 2004-09-29
UY27185A1 (es) 2002-09-30
BR0207519A (pt) 2005-03-08
DE60212813T2 (de) 2007-01-18
KR20030086276A (ko) 2003-11-07
CA2439299A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO20034925D0 (no) Cykliske N-aroylaminer
EE200300416A (et) Ravimvorm
IS6971A (is) Ný efnasambönd
FI20011478A (fi) Farmaseuttinen koostumus
NO20040053L (no) Syntese av taxol forsterkende midler
NO20033205L (no) Terapeutiske kromanforbindelser
DE50209245D1 (de) Neuroprotektives medikament
FI20022128A (fi) Farmaseuttinen koostumus
NO20041968L (no) Anvendelse av cystationin
ATE415948T1 (de) Geschmacksmaskierte formulierung von clarithromycin
DE50214751D1 (de) Dosiervorrichtung
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
TR200400375T3 (tr) Taksanlarin sabit araliklarla dozlanmasi
NO20041065L (no) Hydroksyfettsulfonsyre-analoger
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
PT1231206E (pt) Composicoes estabilizadas de peroxidicarbonatos organicos
ATA5002002A (de) Vibrator
ATA8202001A (de) Medikamentenapplikator
DE60223671D1 (de) Dosierpumpe
DE60237655D1 (de) Entwicklungsgerät
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
DE50213685D1 (de) Dosiervorrichtung
ATE354561T1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen
DE60234539D1 (de) Geschmacksmaskierte orale zubereitung von telithromycin